Utility of quantitative FDG-PET/CT for the detection of bone marrow involvement in follicular lymphoma: a histopathological correlation study

被引:14
|
作者
Adams, Hugo J. A. [1 ]
Kwee, Thomas C. [1 ]
Fijnheer, Rob [2 ]
Dubois, Stefan V. [3 ]
Blase, Peter E. [4 ]
Nievelstein, Rutger A. J. [1 ]
de Klerk, John M. H. [4 ]
机构
[1] Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, NL-3584 CX Utrecht, Netherlands
[2] Meander Med Ctr, Dept Hematol, Amersfoort, Netherlands
[3] Meander Med Ctr, Dept Pathol, Amersfoort, Netherlands
[4] Meander Med Ctr, Dept Nucl Med, Amersfoort, Netherlands
关键词
Biopsy; Bone marrow; Diagnosis; FDG-PET/CT; Follicular lymphoma;
D O I
10.1007/s00256-014-1919-1
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
To determine the value of visual and quantitative (18) F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (FDG-PET/CT) for the detection of bone marrow involvement in follicular lymphoma, using direct histopathological examination at the right posterior iliac crest as reference standard. This retrospective study included 22 patients with newly diagnosed follicular lymphoma who had undergone FDG-PET/CT before BMB of the right posterior iliac crest. FDG-PET/CT images were visually evaluated for bone marrow involvement in the right posterior iliac crest. Volumes of interest were placed in the right posterior iliac crest to calculate the 3D partial volume corrected mean standardized uptake value (cSUV(mean)), maximum standardized uptake value (SUVmax) and peak standardized uptake value (SUVpeak). Sensitivity and specificity of visual FDG-PET/CT analysis for the detection of bone marrow involvement in the right posterior iliac crest were 0.0 % (95 % confidence interval (CI): 0-32.4 %) and 100 % (95 % CI: 78.5-100 %), respectively. Areas under the receiver-operating characteristic curve of cSUV(mean), SUVmax and SUVpeak for the detection of bone marrow involvement in the right posterior iliac crest were 0.85 (95 % CI: 0.63-0.96), 0.89 (95 % CI: 0.68-0.98) and 0.87 (95 % CI: 0.65-0.97), respectively. Optimal cutoff values for cSUV(mean), SUVmax and SUVpeak were 1.3, 2.1 and 1.7, and yielded sensitivity and specificity combinations of 75.0 % and 85.7 %, 87.5 % and 85.7 % and 87.5 % and 85.7 %, respectively. This histopathological correlation study shows that, unlike visual interpretation of FDG-PET/CT images, quantitative FDG-PET/CT analysis may be beneficial in diagnosing bone marrow involvement by follicular lymphoma.
引用
收藏
页码:1231 / 1236
页数:6
相关论文
共 50 条
  • [41] Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic information (vol 4, pg 1812, 2020)
    Nakajima, Reiko
    Moskowitz, Alison J.
    Michaud, Laure
    Mauguen, Audrey
    Batlevi, Connie Lee
    Dogan, Ahmet
    Schoder, Heiko
    BLOOD ADVANCES, 2020, 4 (15) : 3558 - 3558
  • [42] Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?
    Adams, Hugo J. A.
    Kwee, Thomas C.
    Fijnheer, Rob
    Dubois, Stefan V.
    Nievelstein, Rutger A. J.
    de Klerk, John M. H.
    ACTA RADIOLOGICA, 2015, 56 (10) : 1230 - 1235
  • [43] Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET
    Hugo J. A. Adams
    Thomas C. Kwee
    Malou A. Vermoolen
    Bart de Keizer
    John M. H. de Klerk
    Judit A. Adam
    Rob Fijnheer
    Marie José Kersten
    Jaap Stoker
    Rutger A. J. Nievelstein
    European Radiology, 2013, 23 : 2271 - 2278
  • [44] Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study
    Pelosi, E.
    Penna, D.
    Douroukas, A.
    Bello, M.
    Amati, A.
    Arena, V.
    Passera, R.
    Bisi, G.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 55 (04): : 469 - 475
  • [45] Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma
    Albano, Domenico
    Patti, Caterina
    Lagalla, Roberto
    Midiri, Massimo
    Galia, Massimo
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2017, 45 (04) : 1082 - 1089
  • [46] Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET
    Adams, Hugo J. A.
    Kwee, Thomas C.
    Vermoolen, Malou A.
    de Keizer, Bart
    de Klerk, John M. H.
    Adam, Judit A.
    Fijnheer, Rob
    Kersten, Marie Jose
    Stoker, Jaap
    Nievelstein, Rutger A. J.
    EUROPEAN RADIOLOGY, 2013, 23 (08) : 2271 - 2278
  • [47] Is it time to abandon invasive bone marrow biopsy in Non-Hodgkin's lymphoma (NHL) - A study assessing the correlation of bone marrow involvement on 18 FDG PET/CT imaging and histopathological bone marrow biopsy
    Pai, A.
    EUROPEAN JOURNAL OF CANCER, 2016, 54 : S36 - S36
  • [48] Limitation in the assessment of baseline lymphomatous bone marrow involvement by FDG-PET/CT scan
    Junshik Hong
    Jae Hoon Lee
    Annals of Hematology, 2013, 92 : 565 - 566
  • [49] Limitation in the assessment of baseline lymphomatous bone marrow involvement by FDG-PET/CT scan
    Hong, Junshik
    Lee, Jae Hoon
    ANNALS OF HEMATOLOGY, 2013, 92 (04) : 565 - 566
  • [50] Role of 18F-FDG PET/CT for predicting bone marrow involvement, disease relapse and histopathological transformation in follicular lymphoma—a single centre observation
    Sayan Das
    Raju Gupta
    Jayanta Das
    Soumendranath Ray
    Journal of Radioanalytical and Nuclear Chemistry, 2024, 333 : 1627 - 1632